Goldcrest Capital

Terray Therapeutics, backed by NVentures, has launched a cutting-edge #generativeAI model called COATI-LDM. This model uses multidisciplinary latent diffusion techniques to design small molecules with specific properties. COATI-LDM represents a significant step forward in inverse design for #drugdiscovery and #pharma applications. Terray Therapeutics exemplifies how NVIDIA DGX Cloud can impact #lifesciences applications. Their COATI-LDM model was trained exclusively on a distributed cluster of A100 GPUs in the NVIDIA DGX Cloud, showcasing the platform's powerful capabilities. The COATI-LDM model offers several key features: ✅Control over multiple properties ✅Generation guided by medicinal chemistry preferences ✅Ability to create similar compounds while optimizing specific molecular properties Read the arXiv preprint to learn more https://nvda.ws/3MgI6GG

I couldn’t be more excited to announce our collaboration with AMD. Over the past year Arena has developed and deployed Atlas – the world’s first AI hardware engineer at AMD, a leader in high performance and adaptive computing. The AMD team is using Atlas to enhance next-generation GPU performance optimization. Atlas dramatically accelerates time to market for a new chip by reimagining chip development in an AI-native way. Beyond chips, Atlas can provide reliable, autonomous testing, tuning and debugging for any complex hardware device. According to AMD Chief Software Officer, Andrej Zdravkovic: "Atlas helps streamline the manually-intensive and lengthy process of configurating and testing today's complex GPU technologies, giving our engineers a leg up in maximizing the optimizations for next-generation products." Arena is proud to collaborate with forward-thinking enterprises like AMD, and we are deeply inspired by how our customers use our products to rethink human-machine collaboration for their most critical operations. Read the full press release here: https://lnkd.in/eMFjPw4T Learn more about Atlas here: https://lnkd.in/eAKBNtQs